Form 4: Control Empresarial de Capitales S.A. de C.V. Acquires Additional Shares in ProKidney Corp.
SEC Form 4 Filing
Control Empresarial de Capitales S.A. de C.V. reports the acquisition of 25,000 Class A Ordinary Shares of ProKidney Corp. at a weighted average price of $0.7476 per share.
Summary
- Control Empresarial de Capitales S.A. de C.V. acquired 25,000 Class A Ordinary Shares of ProKidney Corp. on April 17, 2025.
- The shares were purchased at a weighted average price of $0.7476.
- Following the transaction, Control Empresarial beneficially owns 73,455,330 shares, including Class A and Class B Ordinary Shares.
- The Slim Family, as beneficiaries of a Mexican trust that owns Control Empresarial, may be deemed to beneficially own approximately 25.1% of ProKidney's total outstanding shares.
- This percentage is based on 292,697,649 total shares outstanding, comprising 129,536,121 Class A Ordinary Shares and 163,161,528 Class B Ordinary Shares, as disclosed in ProKidney's Form 10-K filed on March 17, 2025.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Positives
- The increased shareholding by Control Empresarial could be interpreted as a sign of confidence in ProKidney's future prospects.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders, providing transparency to the market.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for corporate insiders in the US, ensuring transparency in the market.
- Comparable companies would also be subject to similar reporting requirements for insider transactions.
Stakeholder Impact
- The transaction could have a minor impact on shareholders by potentially influencing the stock price, although the volume of shares purchased is relatively small compared to the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| January 18, 2022 | Date of the Business Combination Agreement between ProKidney and ProKidney LP. |
| February 3, 2022 | Date of Schedule 13D/A filing by the Slim Family and Control Empresarial. |
| June 10, 2022 | Date of ProKidney's Definitive Proxy Statement filed with the SEC. |
| March 17, 2025 | Date of ProKidney's Form 10-K filing with the SEC. |
| April 17, 2025 | Date of the transaction where Control Empresarial acquired 25,000 Class A Ordinary Shares. |
| April 21, 2025 | Date of the Form 4 filing. |
Keywords
ProKidney Corp, Control Empresarial, Slim Family, Class A Ordinary Shares, Class B Ordinary Shares, Beneficial Ownership, Share Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.